Clinical applications of MR spectroscopy in epilepsy.
1H and 31P spectroscopy detects relevant metabolite changes in patients with TLE. Numerous studies confirm reduction in NAA and in the ratio of PCr/Pi. In his 1999 review, Kuzniecky concluded that proton MRS, using single-voxel or chemical shift imaging, lateralizes temporal lobe epilepsy in 65% to 96% of cases, with bilateral changes seen in 35% to 45% of cases, whereas phosphorus MRS shows a lateralizing PCr/Pi ratio in 65% to 75% of the TLE patients. There are indications that these changes are reversible with seizure treatment. Improvements in MRS technology, such as the ability to calculate absolute concentrations, to account for differences be-tween gray and white matter and to achieve better spectral resolution by use of a higher magnetic field strength, will now allow more extensive use of this technique for patients with epilepsy.
NYU Comprehensive Epilepsy Center, New York University School of Medicine, 403 East 34th Street, New York, NY 10016, USA. ruben.kuzniecky@med.nyu.edu
Ruben
R
Kuzniecky
D000596:Amino Acids / Q000378:metabolism; D001921:Brain / Q000378:metabolism*; D004833:Epilepsy, Temporal Lobe / Q000175:diagnosis* / Q000378:metabolism; D006801:Humans; D009682:Magnetic Resonance Spectroscopy; D018377:Neurotransmitter Agents / Q000378:metabolism
D000596:Amino Acids; D018377:Neurotransmitter Agents